Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
Thursday, June 11, 2009 - 10:21
in Health & Medicine
Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study.
Read the whole article on Physorg
More from Physorg
Related
- Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawalThu, 11 Jun 2009, 11:26:40 EDT
- Gene expression findings a step toward better classification and treatment of juvenile arthritisMon, 29 Jun 2009, 13:08:42 EDT
- Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexateTue, 3 Jun 2008, 15:21:42 EDT
- Study affirms effectiveness of medication for juvenile rheumatoid arthritisFri, 9 May 2008, 6:28:42 EDT
- Molecular change may reveal risk of leukemia relapseWed, 30 Apr 2008, 18:56:10 EDT